ANS & SUDO
Autonomic Nervous System (ANS) testing can provide life-saving diagnostics for patients while generating revenue for clinics.
Neuropathy Testing
US rates of chronic illnesses continue to rise annually. Moreover, these diseases are often accompanied with neuropathy, which can create further health risks for patients. Coupled with an aging population, diagnosing neuropathy is a critical component for clinics to provide quality care to their patients. Autonomic Nervous System (ANS) testing can provide life-saving diagnostics for patients while generating revenue for clinics.
Standard of Care
Autonomic Balance Studies – Heart Rate Variability Assessment are well accepted by medical associations around the world as one of the best predictors of specific and non-specific health risk. Scientific and clinical studies have established its usefulness in almost all branches of medicine.
Clear Evaluation of Current and Future Health
Evaluation of current health situation – symptoms, medications and therapy reactions
Assessment of possible adequacy of the recovery process
Focused treatment – onset of chronic situations or severity of the diseases
Identification of abnormalities in cardiovascular, cerebrovascular system and overall health assessment
- Blood circulation status – age of blood vessels based on arterial elasticity, peripheral circulatorystatus, organic/functional abnormality of the blood vessels
- Predictive evaluation and progression of arteriosclerosis in Obesity, Hypertension, Hyperlipidemia andDiabetes
Program Benefits
ANS device can identify patients at risk of sudden death and chronic diseases. Among these medical risks that ANS can uncover include silent heart attacks, hypertension cardiac autonomic neuropathy, and diabetic neuropathy. The QHRV equipment is FDA cleared, as well as non-invasive and painless. In addition, there is no insurance pre-authorization required. The device also features full color reports that can be created immediately. Progressus Revenue program provides our clients with reduced wholesale pricing on clinical supplies to further reduce overhead and increase profits.
ANS & Sudocheck System
The Progressus Revenue ANS program uses the QHRV diagnostic system. Physicians enrolled in our program can now provide their patients with non-invasive neuropathic testing that can assist in identifying hidden illnesses. This powerful 12-minute assessment is administered in the office and requires no specialized technician.
Combined with Progressus Revenue’s proprietary strategies and training, our clients receive an average In Network reimbursement of $300 per patient.
